|
KHDRBS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.362000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.368400E-04 |
| Normal-vs-Stage2 |
4.441000E-01 |
| Normal-vs-Stage3 |
9.077400E-01 |
| Normal-vs-Stage4 |
8.854200E-01 |
| Stage1-vs-Stage2 |
1.533600E-01 |
| Stage1-vs-Stage3 |
7.156600E-04 |
| Stage1-vs-Stage4 |
6.043500E-03 |
| Stage2-vs-Stage3 |
3.686200E-01 |
| Stage2-vs-Stage4 |
5.227000E-01 |
| Stage3-vs-Stage4 |
8.080800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.426200E-02 |
| Normal-vs-AfricanAmerican |
7.732400E-01 |
| Normal-vs-Asian |
9.443800E-01 |
| Caucasian-vs-AfricanAmerican |
6.765500E-02 |
| Caucasian-vs-Asian |
5.841200E-01 |
| AfricanAmerican-vs-Asian |
8.636400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.305150E-01 |
| Normal-vs-Female |
1.824000E-02 |
| Male-vs-Female |
2.057200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.446800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.680470E-02 |
| Normal-vs-Age(61-80Yrs) |
1.156970E-01 |
| Normal-vs-Age(81-100Yrs) |
3.863000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.613400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.824200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.123600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.655800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.339600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.756100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.819100E-04 |
| Normal-vs-Grade 2 |
1.83724999999191E-05 |
| Normal-vs-Grade 3 |
7.415400E-01 |
| Normal-vs-Grade 4 |
3.619900E-02 |
| Grade 1-vs-Grade 2 |
2.505800E-01 |
| Grade 1-vs-Grade 3 |
1.675760E-03 |
| Grade 1-vs-Grade 4 |
6.02029999999809E-05 |
| Grade 2-vs-Grade 3 |
1.15030000003014E-06 |
| Grade 2-vs-Grade 4 |
2.03190000380715E-08 |
| Grade 3-vs-Grade 4 |
9.081500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.40339999621375E-08 |
| Normal-vs-ccB subtype |
1.817440E-01 |
| ccA subtype-vs-ccB subtype |
1.10467190950203E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.841700E-02 |
| Normal-vs-N1 |
2.129800E-01 |
| N0-vs-N1 |
9.426200E-02 |
|
|
